Allergy/Imm Medical News about vaccine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine
Vaccine , 07/30/09

Kitchin N et al. – Administration of an acellular pertussis–containing quadrivalent pre–school booster (Td5ap–IPV; Repevax), with or without measles, mumps and rubella (M–M–R II) vaccine, induced robust antibody responses indicative of protection, regardless of the vaccine used for the primary series. Reactogenicity of Repevax was acceptable and consistent with previous experience.

<< Previous
Polyclonal B Cell Differentiation and Loss of Gastrointestinal...

Next >>
Enrichment and analysis of secretory lysosomes from lymphocyte...